174 related articles for article (PubMed ID: 22871133)
1. C-terminal trans,trans-muconic acid ethyl ester partial retro-inverso pseudopeptides as proteasome inhibitors.
Franceschini C; Trapella C; Calia R; Scotti A; Sforza F; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1034-9. PubMed ID: 22871133
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides.
Franceschini C; Trapella C; Sforza F; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):560-4. PubMed ID: 22380778
[TBL] [Abstract][Full Text] [Related]
3. Studies of C-terminal naphthoquinone dipeptides as 20S proteasome inhibitors.
Scotti A; Trapella C; Ferretti V; Gallerani E; Gavioli R; Marastoni M
J Enzyme Inhib Med Chem; 2016; 31(3):456-63. PubMed ID: 25942361
[TBL] [Abstract][Full Text] [Related]
4. α- and β-hydrazino acid-based pseudopeptides inhibit the chymotrypsin-like activity of the eukaryotic 20S proteasome.
Bordessa A; Keita M; Maréchal X; Formicola L; Lagarde N; Rodrigo J; Bernadat G; Bauvais C; Soulier JL; Dufau L; Milcent T; Crousse B; Reboud-Ravaux M; Ongeri S
Eur J Med Chem; 2013; 70():505-24. PubMed ID: 24185380
[TBL] [Abstract][Full Text] [Related]
5. Peptido sulfonyl fluorides as new powerful proteasome inhibitors.
Brouwer AJ; Jonker A; Werkhoven P; Kuo E; Li N; Gallastegui N; Kemmink J; Florea BI; Groll M; Overkleeft HS; Liskamp RM
J Med Chem; 2012 Dec; 55(24):10995-1003. PubMed ID: 23170994
[TBL] [Abstract][Full Text] [Related]
6. Development of peptidomimetic boronates as proteasome inhibitors.
Micale N; Ettari R; Lavecchia A; Di Giovanni C; Scarbaci K; Troiano V; Grasso S; Novellino E; Schirmeister T; Zappalà M
Eur J Med Chem; 2013 Jun; 64():23-34. PubMed ID: 23639651
[TBL] [Abstract][Full Text] [Related]
7. Vinyl ester-based cyclic peptide proteasome inhibitors.
Baldisserotto A; Marastoni M; Fiorini S; Pretto L; Ferretti V; Gavioli R; Tomatis R
Bioorg Med Chem Lett; 2008 Mar; 18(6):1849-54. PubMed ID: 18294845
[TBL] [Abstract][Full Text] [Related]
8. Pseudopeptides with aldehyde or vinylsulfone warheads: Synthesis and antiproteasomal activity.
Jorda R; Molitorová V; Pilařová E; Vojáčková V; Řezníčková E; Svobodová K; Pauk K; Imramovský A; Kryštof V
Bioorg Chem; 2021 Oct; 115():105228. PubMed ID: 34371374
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis and absolute stereochemistry of the proteasome inhibitors cystargolides A and B.
Tello-Aburto R; Hallada LP; Niroula D; Rogelj S
Org Biomol Chem; 2015 Oct; 13(40):10127-30. PubMed ID: 26400369
[TBL] [Abstract][Full Text] [Related]
10. Potent proteasome inhibitors derived from the unnatural cis-cyclopropane isomer of Belactosin A: synthesis, biological activity, and mode of action.
Kawamura S; Unno Y; List A; Mizuno A; Tanaka M; Sasaki T; Arisawa M; Asai A; Groll M; Shuto S
J Med Chem; 2013 May; 56(9):3689-700. PubMed ID: 23547757
[TBL] [Abstract][Full Text] [Related]
11. Naphthoquinone amino acid derivatives, synthesis and biological activity as proteasome inhibitors.
Marastoni M; Trapella C; Scotti A; Fantinati A; Ferretti V; Marzola E; Eleonora G; Gavioli R; Preti D
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):865-877. PubMed ID: 28657369
[TBL] [Abstract][Full Text] [Related]
12. Peptidyl vinyl ester derivatives: new class of selective inhibitors of proteasome trypsin-like activity.
Marastoni M; Baldisserotto A; Cellini S; Gavioli R; Tomatis R
J Med Chem; 2005 Jul; 48(15):5038-42. PubMed ID: 16033282
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors.
Marastoni M; Scotti A; Trapella C; Ferretti V; Sforza F; Gavioli R
J Pept Sci; 2014 Apr; 20(4):258-65. PubMed ID: 24677765
[TBL] [Abstract][Full Text] [Related]
14. N-terminal-prolonged vinyl ester-based peptides as selective proteasome beta1 subunit inhibitors.
Baldisserotto A; Destro F; Vertuani G; Marastoni M; Gavioli R; Tomatis R
Bioorg Med Chem; 2009 Aug; 17(15):5535-40. PubMed ID: 19577931
[TBL] [Abstract][Full Text] [Related]
15. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and pharmacology of proteasome inhibitors.
Rentsch A; Landsberg D; Brodmann T; Bülow L; Girbig AK; Kalesse M
Angew Chem Int Ed Engl; 2013 May; 52(21):5450-88. PubMed ID: 23526565
[TBL] [Abstract][Full Text] [Related]
17. Indolo-phakellins as β5-specific noncovalent proteasome inhibitors.
Beck P; Lansdell TA; Hewlett NM; Tepe JJ; Groll M
Angew Chem Int Ed Engl; 2015 Feb; 54(9):2830-3. PubMed ID: 25581903
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the 26S proteasome by peptide mimics of the coiled-coil region of its ATPase subunits.
Inobe T; Genmei R
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):143-50. PubMed ID: 26522225
[TBL] [Abstract][Full Text] [Related]
19. C-terminal constrained phenylalanine as a pharmacophoric unit in peptide-based proteasome inhibitors.
Baldisserotto A; Marastoni M; Lazzari I; Trapella C; Gavioli R; Tomatis R
Eur J Med Chem; 2008 Jul; 43(7):1403-11. PubMed ID: 17996987
[TBL] [Abstract][Full Text] [Related]
20. Computational inhibition studies of the human proteasome by argyrin-based analogues with subunit specificity.
Loizidou EZ; Zeinalipour-Yazdi CD
Chem Biol Drug Des; 2014 Jul; 84(1):99-107. PubMed ID: 24521156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
